Hinge Health公布的2025年第三季度营收为1.54亿美元（同比增长53%），但每股收益(EPS)不及预期，为-0.02美元，而预期为0.09美元，导致股价在盘后交易中下跌2.66%。 营业利润率从2024年第三季度的-4%提高至20%，而毛利率从去年同期的79%提高至83%。 该公司将全年营收预期上调至5.72亿至5.74亿美元（同比增长47%），并预计第四季度营收在1.55亿至1.5 ...
Investing.com - Needham重申对 Hinge Health Inc (NYSE:HNGE) 的"买入"评级和59.00美元的目标价，并将其评为该公司2026年健康科技领域的首选股票。目前，该股票交易价格为46.88美元，较Needham的目标价低约24%，而更广泛的分析师共识也持看涨态度，评级为1.6（其中1为强烈买入）。
SAN FRANCISCO--(BUSINESS WIRE)-- Hinge Health, Inc. (HNGE) announced today that it will report its financial results for the quarter ended September 30, 2025, after the U.S. markets close on Tuesday, ...
SAN FRANCISCO--(BUSINESS WIRE)--Hinge Health announced a new collaboration with Amazon Health Services to feature Hinge Health’s leading musculoskeletal (MSK) care platform on Amazon.com. Hinge Health ...
SAN FRANCISCO--(BUSINESS WIRE)-- Hinge Health, Inc. (HNGE) announced today that it will report its financial results for the quarterly period ended June 30, 2025, after the close of the market on ...
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Sign up for our newsletter to get the latest on the transformative ...
Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈